Source: Annual Congress 2006 - Cystic fibrosis lung disease: infection, inflammation or both?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Schelstraete, F. De Baets, F. Haerynck, L. Van Simaey, G. Claeys, M. Vaneechoutte, S. Van daele, K. De Boeck, J. Leclercq-Foucart, P. Lebecq, A. Malfroot (Ghent, Leuven, Liege, Louvain La Neuve, Brussels, Belgium). Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes?. Eur Respir J 2006; 28: Suppl. 50, 2802

Member's Comments

No comment yet.

Related content which might interest you: Newly acquired pseudomonas aeruginosa (P.a.) in Belgian CF-patients: does the patients‘ P.a. genotype correlate with environmental genotypes? Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017 Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105 Year: 2006 Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 Training dogs to differentiate Pseudomonas aeruginosa from other cystic fibrosis bacterial pathogens: not to be sniffed at? Source: Eur Respir J, 54 (5) 1900970; 10.1183/13993003.00970-2019 Year: 2019 Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres Source: Eur Respir J 2013; 41: 1091-1100 Year: 2013 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014